From “contraindicated” to “first line” – Current mechanistic insights beyond canonical β-receptor signaling

Author:

Brand Theresa,Lukannek Ann-Kathrin,Jahns Valérie,Jahns Roland,Lorenz KristinaORCID

Publisher

Elsevier BV

Reference61 articles.

1. Beta-blockers in cardiovascular therapy : a review;Diaconu;J Mind Med Sci,2019

2. β-Adrenergic receptor blockade in chronic heart failure;Bristow;Circulation,2000

3. Effect of chronic beta-Adrenergic receptor blockade in congestive cardiomyopathy;Waagstein;Heart,1975

4. Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure;Fung;Am J Cardiol,2003

5. The use of β-blockers in heart failure with reduced ejection fraction;Masarone;J. Cardiovasc. Dev. Dis.,2021

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. “Cardiac glycosides”—quo vaditis?—past, present, and future?;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-07-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3